AITHENON
AI Disease prediction and diagnosis flatform
AITHENON is an AI-based disease prediction and diagnosis platform that predicts and diagnoses the risk of various diseases using health check-up data.
As an additional feature, it enables the creation of AI models specific to any disease by simply inputting disease data. The AI learns from this data and can perform prediction or diagnosis tasks for the given disease.
Since the COVID-19 pandemic, the healthcare market has experienced a paradigm shift from reactive care focused on treatment after disease onset to preventive health management emphasizing proactive individual participation in wellness.
In 2022, the global wellness market was valued at %5.6 of the global GDP (*Report on the Growth of the Global Wellness Industry and Promising Export Sectors of South Korea, Korea International Trade Association International Trade Research Institute).
As of 2022, the Global Wellness Institute (GWI), Unit: billion USD
With the growth of the wellness industry, South Korea's health check-up market exceeded 4 trillion KRW in 2022 and is experiencing rapid expansion.
AITHENON leverages health check-up data to predict major diseases such as cardiovascular and brain disorders. If a likelihood of disease onset is detected, it alerts users to their risk level, enabling proactive prevention of high-risk conditions.
Notably, AITHENON can also predict the risk of most kajor cancers, excluding pancreatic cancer, using only general health check-up data.
South Korea's cancer incidence rate (275.4 cases per 100,000 population) is lower than the OECD average (301.1 cases) but has been steadily increasing since 2016. As of 2020, the number of new cancer cases annually surpassed 250,000. While the incidence rates of stomach, colorectal, liver, and cervical cancers have declined over the past decade, breast cancer has shown a consistent upward trend for 20 years, exceeding 25,000 cases in 2020.
Prediction of Angina Risk
AITHENON achieves significant socioeconomic impacts by facilitating the early detection of critical diseases. Its benefits include:
- Reducing Annual Healthcare Cost: By enabling early diagnosis and prevention, AITHENON helps save 2.3 trillion KRW in medical expenses annually.
- Generating Additional Revenue for Healthcare Institutions: Early detection allows for targeted recommendations of advanced diagnostic tests for potential patients, contributing to 1.1 trilion KRW in new annual revenue for medical facilities.
Thease outcomes highlight the multifaceted ripple effects of AITHENON health check-ups, benefiting individuals, hospitals, and the nation alike.
